Literature DB >> 2506499

Postoperative instillation of mitomycin C in the treatment of recurrent pterygium.

S Hayasaka1, S Noda, Y Yamamoto, T Setogawa.   

Abstract

We examined retrospectively 61 eyes of 61 patients with recurrent pterygia who had been treated with excision, with or without 0.02% mitomycin C instillation, 3 to 7 years after treatment. The rates of recurrence (5% to 9%) and complications in eyes that had undergone excision and mitomycin C instillation were less than those in eyes that had had excision only. These data suggest that the postoperative instillation of 0.02% mitomycin C, twice a day for five days, may be effective and safe in the treatment of recurrent pterygium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506499

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  9 in total

1.  Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium.

Authors:  L Mastropasqua; P Carpineto; M Ciancaglini; P Enrico Gallenga
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

2.  Cell cycle kinetics in pterygium at three latitudes.

Authors:  S R Karukonda; H W Thompson; R W Beuerman; D S Lam; R Wilson; S J Chew; T L Steinemann
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

3.  Effects of topical mitomycin C on primary trabeculectomies and combined procedures.

Authors:  V P Costa; M R Moster; R P Wilson; C M Schmidt; S Gandham; M Smith
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

4.  Mitomycin C for pterygium: long term evaluation.

Authors:  F Raiskup; A Solomon; D Landau; M Ilsar; J Frucht-Pery
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

5.  Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.

Authors:  R Rachmiel; H Leiba; S Levartovsky
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

6.  Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision.

Authors:  Kazuomi Hanada; Noriko Nishikawa; Naoyuki Miyokawa; Akitoshi Yoshida
Journal:  Int Ophthalmol       Date:  2016-04-09       Impact factor: 2.031

7.  Occlusion of the retinal vasculature after trabeculectomy with mitomycin C.

Authors:  R M Nuyts; H A Van Diemen; E L Greve
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

8.  Biomechanical Modeling of Pterygium Radiation Surgery: A Retrospective Case Study.

Authors:  Bojan Pajic; Daniel M Aebersold; Andreas Eggspuehler; Frederik R Theler; Harald P Studer
Journal:  Sensors (Basel)       Date:  2017-05-24       Impact factor: 3.576

9.  Outcomes of preoperative intrapterygial injection of mitomycin C for pterygium excision with and without inferior conjunctival flap.

Authors:  Ved Prakash Gupta; Shekhar Sanghi; Jolly Rohatgi; Upreet Dhaliwal
Journal:  Oman J Ophthalmol       Date:  2019-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.